Skip to main content

Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals

Abstract

Background

Both liver transplantation (LT) and liver resection (LR) represent curative treatment options for hepatocellular carcinoma (HCC) in patients with liver cirrhosis. In this study, we have compared outcomes between historical and more recent patient cohorts scheduled either for LT or LR, respectively.

Methods

Clinicopathological data of all patients with HCC and cirrhosis who underwent LT or LR between 1989 and 2011 were evaluated. Overall survival of patients with HCC within the Milan criteria (MC) was analyzed focusing on changes between different time periods.

Results

In total, 364 and 141 patients underwent LT and LR for HCC in cirrhosis, respectively. Among patients with HCC within MC, 214 and 59 underwent LT and LR, respectively. Postoperative morbidity (37 vs. 11%, P < .0001), but not mortality (3 vs. 1%, P = .165), was higher after LR than after LT for HCC within MC. In the period 1989–2004, overall survival (OS) was significantly higher in patients who underwent LT compared to LR for HCC within MC (5-year OS: 77 vs. 36%, P < .0001). Interestingly, in the more recent period 2005–2011, OS was comparable between LT and LR for HCC within MC (5-year OS: 73 vs. 61%, P = .07).

Conclusion

We have noted an improvement of outcomes among patients selected for partial hepatectomy in recent years that were comparable to stable results after LT in cirrhotic patients with HCC. Whether those improvements are due to advances in liver surgery, optimized perioperative managament for patients with liver cirrhosis, and the development of modern multimodal treatment strategies for the recurrent lesions appears plausible.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. FerlayJ, SoerjomataramI, DikshitR, EserS, MathersC, RebeloM, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer2015;136:86.

    Article  CAS  Google Scholar 

  2. MazzaferroV, RegaliaE, DociR, AndreolaS, PulvirentiA, BozzettiF, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med1996;334:693–9.

    Article  PubMed  CAS  Google Scholar 

  3. NiehuesSM, UngerJK, MalinowskiM, NeymeyerJ, HammB, StockmannM. Liver volume measurement: reason of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it. Eur J Med Res2010;15:345–50.

    Article  PubMed  PubMed Central  Google Scholar 

  4. StockmannM, LockJF, RieckeB, HeyneK, MartusP, FrickeM, et al.Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg2009;250:119–25.

    Article  PubMed  Google Scholar 

  5. PronethA, ZemanF, SchlittHJ, SchnitzbauerAA. Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol2014;21:3096–107.

    Article  PubMed  Google Scholar 

  6. ZhengZ, LiangW, MilgromDP, ZhengZ, SchroderPM, KongNS, et al. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a metaanalysis of observational studies. Transplantation2014;97:227–34.

    Article  PubMed  Google Scholar 

  7. JaraM, ReeseT, MalinowskiM, ValleE, SeehoferD, PuhlG, et al. Reductions in posthepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments. Hpb (Oxford)2015;17:651–8.

    Article  Google Scholar 

  8. AndreouA, GulS, PascherA, SchoningW, Al-AbadiH, BahraM, et al. Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma. Hpb (Oxford)2015;17:168–75.

    Article  Google Scholar 

  9. FaberW, StockmannM, SchirmerC, MollerarndA, DeneckeT, BahraM, et al. Significant impact of patient age on outcome after liver resection for HCC in cirrhosis. Eur J Surg Oncol2014;40:208–13.

    Article  PubMed  CAS  Google Scholar 

  10. GretenTF, MalekNP, SchmidtS, ArendsJ, BartensteinP, BechsteinW, et al. Diagnosis of and therapy for hepatocellular carcinoma. Z Gastroenterol2013;51:1269–326.

    Article  PubMed  CAS  Google Scholar 

  11. DhirM, MelinAA, DouaiherJ, LinC, ZhenWK, HussainSM, et al. A Review And Update Of Treatment Options And Controversies In The Management Of Hepatocellular Carcinoma. Ann Surg2016;263:1112–25.

    Article  PubMed  Google Scholar 

  12. RahmanA, AssifiMM, PedrosoFE, MaleyWR, SolaJE, LavuH, et al. Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis. J Gastrointest Surg2012;16:1897–909.

    Article  PubMed  Google Scholar 

  13. DhirM, LydenER, SmithLM, AreC. Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. Hpb (Oxford)2012;14:635–45.

    Article  Google Scholar 

  14. WangC-C, IyerSG, LowJK, LinC-Y, WangS-H, LuS-N, ChenC-L. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol2009;16:1832–42.

    Article  PubMed  Google Scholar 

  15. HasegawaK, MakuuchiM, KokudoN, IzumiN, IchidaT, KudoM, et al. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg2014;259:166–70.

    Article  PubMed  Google Scholar 

  16. Mirici-CappaF, GramenziA, SantiV, ZambruniA, DiMicoliA, FrigerioM, et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut2010;59:387–96.

  17. ZaydfudimVM, VachharajaniN, KlintmalmGB, JarnaginWR, HemmingAW, DoyleMBM, et al. Liver Resection And Transplantation For Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg264:650–82016.

  18. MiseY, HasegawaK, ShindohJ, IshizawaT, AokiT, SakamotoY, et al. The Feasibility Of Third Or More Repeat Hepatectomy For Recurrent Hepatocellular Carcinoma. Ann Surg2015;262:347–57.

    Article  PubMed  Google Scholar 

  19. FacciorussoA, DiMasoM, MuscatielloN. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and metaanalysis. Int J Hyperthermia2016;32:339–44.

    Article  PubMed  CAS  Google Scholar 

  20. LencioniR, De BaereT, SoulenMC, RillingWS, GeschwindJ-FH. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Hepatology2016;64:106–16.

    Article  PubMed  CAS  Google Scholar 

  21. SchnapauffD, CollettiniF, HartwigK, WienersG, ChopraS, HammB, GebauerB. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection. Anticancer Res2015;35:319–23.

    PubMed  Google Scholar 

  22. AndreouA, VautheyJ-N, CherquiD, ZimmittiG, RiberoD, TrutyMJ, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg2013;17:66–77; discussion 77.

    Article  PubMed  Google Scholar 

  23. SeehoferD, SucherR, SchmelzleM, OllingerR, LedererA, DeneckeT, et al. Entwicklung der laparoskopischen Leberchirurgie als Standardverfahren beim HCC in Zirrhose? Z Gastroenterol55:453–4602017.

  24. LiuL, WangZ, JiangS, ShaoB, LiuJ, ZhangS, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a metaanalysis. Plos One2013;8:E64261.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. SeehoferD, OllingerR, DeneckeT, SchmelzleM, AndreouA, SchottE, PratschkeJ. Blood Transfusions And Tumor Biopsy May Increase Hcc Recurrence Rates After Liver Transplantation. J Transplant2017;2017:9731095.

    Article  PubMed  PubMed Central  Google Scholar 

  26. HaradaN, ShirabeK, MaedaT, KayashimaH, IshidaT, MaeharaY. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients. World J Surg2015;39:1044–51.

    Article  PubMed  Google Scholar 

  27. AndertA, LodewickT, UlmerTF, SchmedingM, SchoningW, NeumannU, et al. Liver resection in the elderly: A retrospective cohort study of 460 patients—Feasible and safe . Int J Surg2016;28:126–30.

    Article  PubMed  Google Scholar 

  28. MalinowskiM, JaraM, LuttgertK, OrrJ, LockJF, SchottE, StockmannM. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test. Dig Dis Sci2014;59:2983–91.

    Article  PubMed  CAS  Google Scholar 

  29. LockJF, MalinowskiM, SeehoferD, HoppeS, RohlRI, NiehuesSM, et al. Function and volume recovery after partial hepatectomy: influence of preoperative liver function, residual liver volume, and obesity. Langenbecks Arch Surg2012;397:1297–304.

    Article  PubMed  Google Scholar 

  30. JaraM, BednarschJ, ValleE, LockJF, MalinowskiM, SchulzA, et al. Reliable assessment of liver function using LiMAx. J Surg Res2015;193:184–9.

    Article  PubMed  CAS  Google Scholar 

  31. VautheyJ-N, PawlikTM, AbdallaEK, ArensJF, NemrRA, WeiSH, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg2004;239:722–30; discussion 730-2.

    Article  PubMed  PubMed Central  Google Scholar 

  32. HoekstraLT, De GraafW, NibourgGAA, HegerM, BenninkRJ, StiegerB, VanGulikTM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg2013;257:27–36.

    Article  PubMed  Google Scholar 

  33. KishiY, AbdallaEK, ChunYS, ZorziD, MadoffDC, WallaceMJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg2009;250:540–8.

    PubMed  Google Scholar 

  34. JochmansI, VanRosmalenM, PirenneJ, SamuelU. Adult Liver Allocation In Eurotransplant. Transplantation2017;101:1542–50.

    Article  PubMed  Google Scholar 

  35. IoannouGN, PerkinsJD, CarithersRL, Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology2008;134:1342–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

Felix Krenzien, Benjamin Struecker, Nathanael Raschzok, Christian Benzing, Maximilian Jara, Marcus Bahra, Robert Öllinger, Igor M. Sauer, Andreas Pascher, Moritz Schmelzle, Johann Pratschke, Andreas Andreou: contribution meets all criteria.

Corresponding author

Correspondence to Andreas Andreou.

Ethics declarations

This retrospective study was conducted at the Department of Surgery of the Charité, Campus Virchow-Klinikum, Berlin, Germany, and was officially approved by the Institutional Review Board (EA2/150/13).

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Accepted for oral presentation at the 12th Biennial International Congress of the European-African Hepato-Pancreato-Biliary Association in Mainz, Germany, May 2017.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Krenzien, F., Schmelzle, M., Struecker, B. et al. Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals. J Gastrointest Surg 22, 840–848 (2018). https://doi.org/10.1007/s11605-018-3690-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-018-3690-4

Keywords

  • Hepatocellular carcinoma
  • Liver transplantation
  • Liver resection